Daewoong Pharma (069620) — Financial Flexibility Index
Daewoong Pharma (069620) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of ₩129.75 Billion (operating CF ₩57.53 Billion minus capex ₩72.21 Billion) represents 0% of total liabilities (₩1.26 Trillion). Check Daewoong Pharma investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daewoong Pharma Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Daewoong Pharma across 16 annual periods. For the full cash flow conversion analysis, see Daewoong Pharma cash conversion from operations.
Annual Financial Flexibility Index for Daewoong Pharma (2007–2024)
Year-by-year free cash flow to debt coverage for Daewoong Pharma. Explore Daewoong Pharma (069620) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | ₩280.50 Billion | ₩51.49 Billion | ₩1.05 Trillion | ▼ -18.9% |
| 2023 | 0.33x | ₩251.24 Billion | ₩132.57 Billion | ₩762.77 Billion | ▲ +47.6% |
| 2022 | 0.22x | ₩183.44 Billion | ₩118.21 Billion | ₩822.12 Billion | ▲ +130.2% |
| 2021 | 0.10x | ₩69.08 Billion | ₩39.99 Billion | ₩712.77 Billion | ▼ -48.9% |
| 2020 | 0.19x | ₩127.47 Billion | ₩100.98 Billion | ₩671.66 Billion | ▲ +44.8% |
| 2019 | 0.13x | ₩79.91 Billion | ₩57.60 Billion | ₩609.75 Billion | ▼ -24.7% |
| 2018 | 0.17x | ₩104.49 Billion | ₩47.50 Billion | ₩600.04 Billion | ▼ -41.4% |
| 2017 | 0.30x | ₩173.06 Billion | ₩103.94 Billion | ₩581.99 Billion | ▼ -10.1% |
| 2016 | 0.33x | ₩178.63 Billion | ₩15.38 Billion | ₩540.15 Billion | ▼ -8.0% |
| 2015 | 0.36x | ₩131.02 Billion | ₩35.89 Billion | ₩364.29 Billion | ▲ +19.4% |
| 2014 | 0.30x | ₩71.95 Billion | ₩25.95 Billion | ₩238.76 Billion | ▼ -41.9% |
| 2013 | 0.52x | ₩73.20 Billion | ₩54.16 Billion | ₩141.05 Billion | ▼ -27.8% |
| 2012 | 0.72x | ₩68.79 Billion | ₩45.02 Billion | ₩95.76 Billion | ▼ -18.4% |
| 2011 | 0.88x | ₩119.74 Billion | ₩78.82 Billion | ₩136.04 Billion | ▲ +173.8% |
| 2008 | 0.32x | ₩66.67 Billion | ₩31.33 Billion | ₩207.39 Billion | ▼ -35.8% |
| 2007 | 0.50x | ₩61.70 Billion | ₩25.81 Billion | ₩123.24 Billion | — |